11th Annual Healthtech Investment Forum 2024 | Sachs Associates Ltd | 23 September 2024 | Movenpick Hôtel Bâle, Aeschengraben 25, 4051 Basel, Switzerland

• Mapping the Future of Global HealthTech Panel
• Digital Pharma Innovation Panel: Leveraging Big Data & AI
• Future Patient’s Journey Panel: Data & Diagnostics
• MedTech & Device Markets Panel: Innovation & Capital
• Advanced Technologies Panel: Focusing on CardioTech Innovation
• Corporate & Financial Investors Roundtable
• Rising Stars – HealthTech Seed Companies Session

Participation Options:
Complimentary passes are provided for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes is limited, and priority is given to regular participants, however the organiser has the discretion to reject registrations. Other participants may consider purchasing access, which includes in-person or virtual participation, with different options to showcase your company.

Networking Opportunities:
The Online Meeting System will open on the 10th of September for uploading profiles and sending meeting invites. The in-person meetings will be taking place on the 24th of September, while virtual meetings will take place on the 2nd - 4th of October. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings.

Presenting Opportunities:
Presentations are a popular and useful way to gain additional exposure with potential investors and pharma partners, who make up over half the audience. We are pleased to announce that once again we will have 20-minute and 10-minute presentations taking place in-person at the dedicated parallel presenting tracks. Here you will be able to showcase your company in front of investors attending the physical event. The recording will be added to your company’s profile later and will be available on-demand for registered participants until the event portal closes. Start-up companies, which are looking for seed financing can apply for a HealthTech Rising Stars – Seed Companies Session and chosen participants will receive a complimentary 5-minute elevator pitch as part of the main programme (subject to delegate registration fee).

For those who are not able to present in-person, but are still interested in showcasing their company, there is an option to purchase either a 20 or a 10-minute presentation, which will be pre-recorded in advance and available to all registered attendees during the virtual conference week on the events portal. Start-up companies, which are looking for seed financing are also offered an option to make a 5-minute pre-recorded showcase instead.

The Sachs Team can assist with the pre-recording of the presentation, or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.

2024 Speakers

KEYNOTES:

Ruthy Kaidar
Managing Director Healthcare, EMEA, Microsoft Corporation

Jeffrey Cohen
Director of Research, Ladenburg Thalmann & Co. Inc.

SPEAKERS:

Alexandra Vallon Eberhard
Senior Director - CTO, Global Strategy & Partnering, Roche Diagnostics

Ali Tinazli
CEO, Lifespin GmbH

Andreas Wüpper
Managing Director, Fresenius Medical Care Ventures GmbH

Angela Zubel
CDO, Debiopharm International SA

Beat Merz
Managing Director, New Harbor Venture Partners, LLC

Beatriz Volckaert
Principal, Philips Ventures

Boris Bogdan
Lead HCLS EMEA, Amazon Web Services

Bracy Fertig
VP Strategy & Corporate Development, Caresyntax Corp.

Cem Baydar
Chief Investment Officer, Eczacibasi Pharmaceutical and Industrial Investment Co.

Christian Hein
Executive Advisor & Board Member, Quant Health

Christian Kannemeier
Sr. Investment Manager, High-Tech Gründerfonds

Christian Schenk
Investment Director, Apposite Capital LLP

Daniel Parera
Partner, Kurma Partners

Diana Saraceni
Co-Founder & General Partner, Panakès Partners SGR SpA

Edouard Gobitz
Managing Partner, Asklepios Advisors

Eli Yered
CFO, Sanara Ventures

Elie Lobel
CEO, RDS SAS

Eric de La Fortelle
Managing Partner, Cathay Health

Eyal Lifschitz
Co-Founder & General Managing Partner, Peregrine Ventures

Filippo Piatti
Co-Founder & CEO, Artiness S.r.l

Giancarlo Rizzoli
CEO, 4D Lifetec AG

Isaac Middelmann
Accelerator Director - Strategic Fundraising, EIT Health e.V.

Jean-Pierre Pennacino
CFO, MedAlliance SA

Katrin Vatiska
Investment Partner, MTIP AG

Konrad Dobschuetz
Global HealthTech Leader, former National Director NHS Innovation Accelerator, Independent

Laurent Choppe
Managing Partner, Cukierman & Co. Life Sciences

Leo Smit
CEO, Hy2Care B.V.

Marco Wendel
Managing Director, Medical Valley EMN e.V.

Marianne Mertens
Partner, Apollo Health Ventures

Marina Izzo
CEO, EBAMed SA

Nitzan Hirsh
Co-Founder & CEO, LuSeed Vascular

Rainer Metzger
Head of Integrated Clinical Services, Medicover AB

Remi Spagnol
Investment Director, Supernova Invest

Roman Schenk
Managing Partner, INOGROUP GmbH

Sarah Des Rosiers
Director, Health Equity, Novartis Foundation

Stephan Wehrli
Investment Principal & Partner, Zühlke Ventures AG

Tamara Gerbert
Founder, VP of Strategy & Director of Neuroscience, Brightmind.AI GmbH

Tanja Dowe
Managing Director, Angelini Ventures S.p.A.

Todor Jeliaskov
Chairman & CEO, inHEART

Ulrich Muehlner
Co-Founder & CEO, GrowthCube Partners LLC

2024 Sponsors

SUPPORTERS:
• Berlin Partner
• Bio Deutschland
• BiA
• Bio Partner
• Biopole
• Biotech Gate
• Edison
• Eit Health
• European Healthcare Investor Association
• FreeMind
• Instinctif
• Lyonbiopole
• MedEdge
• Medistrava
• MedNous
• Optimum
• Life Sciences
• Seca
• Swiss Biotech Association
• Tiberend